Health Risks of Ionizing Radiation: - Clark University
Health Risks of Ionizing Radiation: - Clark University
Health Risks of Ionizing Radiation: - Clark University
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
Figure 5-2. Military observers shield their faces from the<br />
Teapot Test in 1955 (http://www.aracnet.com/~pdxavets/).<br />
<strong>of</strong> blood and lymph cancers including leukemia.<br />
Darby et al. (1988, 1993) and Muirhead et al. (2003)<br />
conducted a cohort follow-up <strong>of</strong> 20,000 British test<br />
veterans through 1998 and found that the leukemia<br />
mortality rate, while not much greater than the<br />
national rate, was significantly higher than in a<br />
control population (servicemen not participating in<br />
the tests). For the follow up through 25 years the<br />
relative risk (RR) was 3.38 (90% CI 1.45-8.25). 2<br />
New Zealand servicemen also participated in the<br />
same tests as the British servicemen and were also<br />
found to have increased leukemia mortality (RR 5.6;<br />
90% CI 1.0-41.7; Pearce et al. 1990, 1997). 3<br />
Several studies <strong>of</strong> U.S. servicemen have also<br />
found evidence <strong>of</strong> increased leukemia. Caldwell et<br />
al. (1983) followed 3,217 participants in the 1957<br />
test “Smoky” through 1979 and found an increase<br />
Nuclear Weapons Testing 59<br />
in both leukemia incidence (RR 2.50; 1.20-4.60)<br />
and leukemia mortality (RR 2.58; 1.11-5.09). The<br />
same authors, looking at the same cohort, also<br />
found four cases <strong>of</strong> polycythemia vera, another<br />
type <strong>of</strong> blood neoplasm, when 0.2 cases would be<br />
expected in this population based on national rates<br />
(Caldwell et al. 1984). This translates into a relative<br />
risk <strong>of</strong> 20.2 (5.5-51.7). Dalager et al. (2000) found<br />
statistically significant increases in mortality from<br />
lymphopoietic cancers (RR 3.72; 1.28-10.83) and<br />
all-cause mortality (RR 1.22; 1.04-1.44) when<br />
comparing U.S. test veterans with high doses (> 50<br />
mSv) to veterans with “minimal” doses.<br />
The leukemia association is less clear in some<br />
other studies <strong>of</strong> U.S. veterans. Johnson et al. (1997)<br />
studied the mortality <strong>of</strong> approximately 40,000<br />
participants in Operation Crossroads, a 1946 test<br />
series at the Bikini atoll. Leukemia mortality was not<br />
significantly elevated (RR 1.02; 0.75-1.39) although<br />
all-cause mortality was (RR 1.05; 1.02-1.07). 4<br />
Watanabe et al. (1995) also found a nonsignificant<br />
increase in leukemia mortality among the 1,094<br />
personnel exposed to more than 1 cGy <strong>of</strong> gamma<br />
radiation during the 1958 test series “Hardtack I”<br />
(RR 1.73; 0.39-7.56). This study looked at a total <strong>of</strong><br />
8,554 veterans and also found significant increases<br />
in total cancer mortality (RR 1.42; 1.03-1.96) and<br />
liver cancer mortality (RR 6.42; 1.17-3.53).<br />
5.2 Semipalatinsk Test Site downwinders<br />
There were 118 atmospheric tests at the<br />
Semipalatinsk Test Site between 1949 and 1963,<br />
and over 300 underground tests through 1989, some<br />
<strong>of</strong> them releasing radioactive material when they<br />
broke the surface (vented). 95% <strong>of</strong> the collective<br />
dose received by nearby residents is thought to<br />
have come from four tests in 1949, 1951, 1953 and<br />
1956. In 1994 Zaridze et al. published a paper that<br />
examined the relationship between childhood cancer<br />
incidence and distance from the test site. They began<br />
2 For the extended follow-up (through 1998) the RR for non-CLL leukemia mortality was significant but lower (1.83,<br />
90% CI 1.15, 2.93). Leukemia incidence risks were similar to those <strong>of</strong> mortality (Muirhead et al. 2003).<br />
3 In this cohort the RR <strong>of</strong> leukemia incidence was the same as the RR <strong>of</strong> leukemia mortality. There was also a significant<br />
excess <strong>of</strong> all hematologic cancers, with a RR <strong>of</strong> 1.9 (0.8-4.3) for incidence and 3.8 (1.4-10.8) for mortality (Pearce<br />
et al. 1997).<br />
4 The subgroup <strong>of</strong> Operation Crossroads participants having an Engineering and Hull specialty showed a<br />
leukemia risk that was close to statistical significance (RR 1.51; 0.94-2.44) (Johnson et al. 1997).